A. Kellogg

Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.

M. Mcgrath, Rohan V Mendonca, J. Janc, 2006, Bioorganic & medicinal chemistry letters.

Prone treatment position as a novel option for head and neck cancer patients with unmanageable secretions

Salahuddin Ahmad, C. Henson, A. Kellogg, 2020, Journal of Radiotherapy in Practice.